Biotech - Spark Newswire

1 minute read

Brooklyn ImmunoTherapeutics Stock Rises After Novellus Therapeutics Buyout Deal

Today, 6:08 AM

Brooklyn ImmunoTherapeutics LLC (NYSE:BTX) has executed a non-binding letter of intent to acquire Novellus Therapeutics, a company developing engineered mesenchymal stem…

BTX

3 minute read

Why Novavax, Orphazyme, Avenue Therapeutics Shares Are Moving Monday

By Shanthi Rexaline

Today, 6:08 AM

Novavax, Inc. (NASDAQ: NVAX), Orphazyme A/S (NASDAQ: ORPH) and Avenue Therapeutics, Inc.

ATXI

1 minute read

Cocrystal Pharma’s Preclinical Protease Inhibitor Effective Against Original, Two Variant COVID-19 Strains

By Vandana Singh

Today, 6:08 AM

Cocrystal Pharma Inc (NASDAQ:COCP) has announced laboratory-based results for its lead preclinical SARS-CoV-2 3CL protease inhibitor, CDI-45205. A third-party laboratory contracted…

COCP

1 minute read

Lipocine To Start Testing Neuro-Steroid Candidate In Postpartum Depression Patients

By Vandana Singh

Today, 6:08 AM

The FDA has signed off Lipocine Inc’s (NASDAQ:LPCN) Investigational New Drug Application (IND) to initiate a Phase 2 study to evaluate…

LPCN

1 minute read

G1 Therapeutics Starts Mid-Stage Bladder Cancer Trial With Cosela

By Vandana Singh

Today, 6:08 AM

G1 Therapeutics Inc (NASDAQ:GTHX) has initiated the PRESERVE 3 Phase 2 study evaluating Cosela (trilaciclib) in patients with untreated, locally advanced,…

GTHX

1 minute read

EyeGate Pharma Stock Jumps On Initiation Of Proof Of Concept Trial With DHODH Inhibitor In Ophthalmology Indications

By Vandana Singh

Today, 6:08 AM

EyeGate Pharmaceuticals Inc (NASDAQ:EYEG) has dosed the patient in Phase 2 proof-of-concept study evaluating its lead product candidate, PP-001, in patients…

EYEG

1 minute read

RAPT Therapeutics Stock Soars As Atopic Dermatitis Candidate Shows Promising Action In Early-Stage Study

By Vandana Singh

Today, 6:08 AM

RAPT Therapeutics Inc (NASDAQ:RAPT) has announced topline results from its Phase 1b trial of RPT193 as monotherapy for moderate-to-severe atopic dermatitis…

RAPT

1 minute read

Lantheus To Present Piflufolastat F 18 Data At Virtual Society Of Nuclear Medicine And Molecular Imaging 2021 Annual Meeting

By Bill Haddad

Today, 6:08 AM

Lantheus Holdings, Inc. (the "Company") (NASDAQ:LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence

LNTH

2 minute read

Omeros Highlights Presentation Of Narsoplimab Pivotal Trial Data In Oral Presentation At 2021 Annual Congress Of European Hematology Association

By Bill Haddad

Today, 6:08 AM

Data on Organ Function Improvement Presented by Chief of Adult Bone Marrow Transplant Service at Memorial Sloan Kettering -- Omeros Corporation (NASDAQ:OMER) today announced that data on organ function improvement from

OMER

2 minute read

FDA
News

Cocrystal’s Says Lead COVID-19 Antiviral CDI-45205 Shown To Be Active Against SARS-CoV-2 And 2 Prominent SARS-CoV-2 Variants

By Benzinga Newsdesk

Today, 6:08 AM

Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the

COCP